Hellmann moves into Arabian market with Healthcare Logistics solution

Published: 1-Feb-2010
Logistics

Hellmann Worldwide Logistics unveiled its global launch of Hellmann Healthcare Logistics at Arab Health 2010 in Dubai last month. The global logistics provider's portfolio will offer an end-to-end logistics operation within the Arabian healthcare industry.


Hellmann Worldwide Logistics unveiled its global launch of Hellmann Healthcare Logistics at Arab Health 2010 in Dubai last month. The global logistics provider's portfolio will offer an end-to-end logistics operation within the Arabian healthcare industry.

Recognising that the pharmaceutical industry extends beyond the manufacturers" doors, Hellmann's key areas of focus will be on processing standards, people and facilities to comply with the regulatory requirements.

Hellmann Healthcare Logistics will be a vertical segmented organisation within Hellmann Worldwide Logistics, which Andreas Lohmeier will head up as global director. He explained: 'Hellmann has gained experience in the pharmaceutical, biotechnology and medical device sectors over many years, but we have never offered an entire global end-to-end solution. It's now time to consolidate all our current dealings into a dedicated solution with a dedicated team which support the entire operation from product launch to warehousing and supply chain designs.'

'Arab Health is the perfect exhibition to announce our Middle East plans, put our solution in front of the industry and more importantly, ensure we are heard, he said

Hellmann Worldwide Logistics is one of the largest privately owned and family run logistical global networks operating from 443 branches across 157 countries.




  • Companies:
  • Hellmann Worldwide Logistics Ltd
See more

You may also like

Media

A year of challenges and innovation in pharma logistics lies head

Read more
Envirotainer CEO, Peter Gisel-Ekdahl, looks to the future and what 2022 holds for pharmaceutical logistics

Trending Articles

  1. Lessons learned: AstraZeneca’s supply chain resilience during the pandemic With 26 manufacturing facilities and a global network of more than 250 suppliers, AstraZeneca’s Global Operations Manufacturing footprint is not only large in scale, it's also highly complex and positioned to deliver medicines to patients worldwide
  2. Supporting the NHS with COVID-19 vaccine roll out Versapak carriers for vaccinations feature VersaShield Antimicrobial Protection to stop the spread of COVID-19
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    The pros and cons of distribution agreements For life sciences companies seeking to break into overseas markets, distribution agreements are central to success
  4. Biotec Services International
  5. Cell Therapy Catapult and TrakCel to collaborate on three year research project Will test TrakCel technology in a GMP-compliant environment

Upcoming event

ASGCT Annual Meeting 2024

7-11 May, 2024 | Meeting | Portland, OR See all

You may also like

Media

A year of challenges and innovation in pharma logistics lies head

Envirotainer CEO, Peter Gisel-Ekdahl, looks to the future and what 2022 holds for pharmaceutical logistics
Packaging

Dachser renews pharma certification in Frankfurt

Drugs and other pharmaceutical products are often temperature-sensitive, urgent shipments that must be handled in compliance with a complex regulatory environment
Pharmaceutical

Lessons learned: AstraZeneca’s supply chain resilience during the pandemic

With 26 manufacturing facilities and a global network of more than 250 suppliers, AstraZeneca’s Global Operations Manufacturing footprint is not only large in scale, it's also highly complex and positioned to deliver medicines to patients worldwide
Digital

The human digital twin: a virtual counterpart to the human worker

Several organisations are familiar with making use of digital twin modelling to improve operations. This digitised model typically enables firms to map the physical characteristics of a production environment as well as its processes. But, this mapping process has limitations because it only includes data from machines and not from humans, which are crucial too
Regulatory

How to comply with regulatory expectations to access compliance data for the entire pharmaceutical supply chain

The pharmaceutical supply chain must work and must be known, is not a novel idea. Anyone involved in this industry’s quality processes knows that mastering 100% of its supply chain has been unachievable in the current state-of-the-art… until now!
Digital

Addressing wastage and distribution challenges for a more equitable post-pandemic pharmaceutical industry

When functioning properly, globalised supply chains broaden access to critical medicines for billions of individuals all over the world. Yet, any number of issues, from macro events such as the recent COVID-19 pandemic or the 2010 volcanic eruption in Iceland, through to more simple patient misunderstandings, can lead to expensive and often unnecessary wastage
Sustainability

Supply Chain Management: Sustainability initiatives

Here Sandeep Oke, Sr Vice President – Supply Chain at Piramal Pharma Solutions discusses why adopting Supply Chain Sustainability can be very rewarding for the business, organisation and wider society
Subscribe now